We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Machine Learning: Helping Determine How a Drug Affects the Brain

News   Nov 16, 2017 | Original story from University College London

 
Machine Learning: Helping Determine How a Drug Affects the Brain

Gaze recovery high-dimensional classifier weights. Represented as 3D cubic glyphs varying in colour and scale are the weights of a transductive linear support vector machine classifier trained to relate the high-dimensional pattern of damage to gaze outcome, achieving k-fold cross-validation performance of 78.33% (SE = 1.70%) sensitivity and 82.78% (SE = 0.56%) specificity for distinguishing between patients who recovered from a leftward deviation of gaze and those who did not. Positive weights (dark blue to cyan) favour recovery, negative weights (dark red to yellow) persistence of symptoms. Though hemispheric asymmetry is prominent, note the distribution of weights is highly complex, as one would expect from the complexity of the functional and lesional architectures that generate the critical pattern. Credit: https://doi.org/10.1093/brain/awx288

 
 
 

RELATED ARTICLES

Researchers Move Closer to Completely Optical Artificial Neural Network

News

Researchers have shown that it is possible to train artificial neural networks directly on an optical chip. The significant breakthrough demonstrates that an optical circuit can perform a critical function of an electronics-based artificial neural network and could lead to less expensive, faster and more energy efficient ways to perform complex tasks such as speech or image recognition.

READ MORE

What Makes Good Brain Proteins Turn Bad?

News

The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.

READ MORE

Kidney Cancer Driver Could Lead to New Treatment Strategy

News

Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE